Skip to main content

Table 2 Patients Demographics of controls and myocarditis patients

From: Diagnostic performance of cardiovascular magnetic resonance native T1 and T2 mapping in pediatric patients with acute myocarditis

  Healthy control (n = 39) Acute myocarditis (n = 23) p-value
Median age at CMR (years) 15.1 (IQR 11.3–17.2) 16.3 (IQR 14.7–17.7) 0.054
Gender (% male) 69% 61% 0.50
ICU Admission 13/23 (56.5%)
Required Inotropes 6/23 (26.1%)
Treated with IVIG 12/23 (52.2%)
Presence of Arrhythmias 4/23 (17.4%)
Elevated Troponin 22/23 (96%)
Time from diagnosis to CMR (days) 4.5 (range, 1–26)
Required Anesthesia for CMR 4/39 (10.3%) 6/23 (26.1%) < 0.001
Left Ventricular Ejection Fraction (%) 57.0 ± 4.8 54.5 ± 7.3 0.17
Indexed LVEDV (ml/m2) 92 ± 16 92 ± 23 0.89
Edema Present (T2W) 13/23 (57%)
Hyperemia Present (T1W) 3/23 (13%)
LGE Present 20/23 (86%)
Met LLC criteria 13/23 (57%)
  1. Mean values listed unless otherwise specified. CMR: Cardiovascular Magnetic Resonance, IQR: Interquartile range, ICU: Intensive Care Unit, IVIG: Intravenous Immunoglublin,, LVEDV: Left ventricular end-diastolic volume, LGE: late gadolinium enhancement, LLC: Lake Louise Criteria